Vaccine News: Medicare to Pay Doctors Treating Injuries
The Trump administration is moving to pay doctors for the time they spend diagnosing and treating patients who believe a vaccine has harmed them, under a new Medicare rule published in the Federal Register. The policy creates a dedicated billing code that lets physicians and other eligible providers charge Medicare for the clinical work involved in evaluating a suspected vaccine injury, a task that until now has had no billing code of its own. The code takes effect on January 1, 2027, and it applies to office visits as well as telehealth appointments.
The change is the most concrete step yet in the administration's overhaul of federal vaccine policy. Supporters describe it as long-overdue recognition that patients who report problems after vaccination deserve careful, unhurried attention. Critics warn that paying doctors specifically for vaccine-injury work could skew clinical judgment, and that the rule leaves the biggest question unanswered: whether the time doctors spend filing official safety reports will be paid for at all.
Vaccine News: What the New Billing Code Covers
The new code is G0576, an add-on code for the diagnosis and treatment of vaccine adverse effects. Under the rule, physicians and other eligible Medicare providers can bill it for every 15 minutes of qualifying work spent evaluating, diagnosing, treating, or counseling a patient with a suspected vaccine-related adverse reaction. The payment sits on top of what Medicare already pays for a standard office visit, so a doctor who spends extra time on a suspected reaction is paid for that extra time rather than absorbing it. CMS has valued the service at 0.97 relative value units, roughly 32 dollars per 15-minute unit before geographic adjustments, with the same valuation for telehealth visits.
To qualify for payment, a doctor must document when the suspected reaction began in relation to the vaccination, evaluate other possible causes of the patient's symptoms, and keep supporting medical records. The bar is deliberately set at suspicion rather than proof. A CMS spokesperson said reimbursement would not depend on a final determination that a vaccine caused the reported symptoms, and that physicians would not be paid based on whether a report was ultimately judged to be related to a vaccine. In other words, the code pays for the investigation itself, not for reaching a particular conclusion. That distinction matters: the rule pays for diagnosing and treating a patient, not for the paperwork of filing a safety report, and that gap is now one of the central disputes around the policy.
RFK Jr News: The MAHA Agenda Behind the Change
CMS framed the new code as part of the Trump administration's Make America Healthy Again initiative, the health agenda led by Health and Human Services Secretary Robert F. Kennedy Jr. In a statement, Kennedy said Medicare should reward clinicians for keeping people healthy, casting the policy as a way to make the health system take patients who report vaccine injuries seriously rather than dismissing them.
The billing code is one piece of a broader package of vaccine-injury measures that Kennedy's department rolled out in early October. On October 8, the Department of Health and Human Services announced a series of actions to strengthen how the federal government identifies, documents, investigates, and responds to health problems reported after vaccination. The package opened a clinic at the National Institutes of Health in Bethesda, Maryland, for patients who report health problems following vaccination, required electronic health records to capture vaccine-related adverse events, and set out to modernize the Vaccine Adverse Event Reporting System, known as VAERS, so reports can be filed from a phone. Kennedy has made vaccine injury tracking a signature promise of his tenure, arguing that the existing system undercounts the problems patients report. The policy also fits a year of sweeping changes: in August, the president signed an executive order that reduced the number of recommended childhood vaccines from 18 to 11 and split the combined measles, mumps, and rubella shot into separate doses.
From Proposal to Final Rule
The path to the new code began in July, when CMS published the proposed rule that sets Medicare physician payment for 2027. The proposal created a code then called GADV1 for the diagnosis and treatment of vaccine adverse effects, billed in 15-minute increments on top of an ordinary visit, with its own payment value. The public comment period closed on September 14, and the proposal drew responses from across the medical world. In a September letter to CMS Administrator Mehmet Oz, the American Academy of Family Physicians said the code overlapped with existing billing codes. The group also said it did not expect the code to be used frequently, because vaccine reactions are not typical and are usually mild. CMS pressed ahead anyway, and the final version was published in the Federal Register last week, with the code renamed G0576. The final rule kept the structure of the proposal, but it left open the same question the proposal had left open. The health department's original October announcement had said CMS would reimburse physicians for the time they spend submitting reports of suspected vaccine injuries to VAERS. The rule itself describes something different: payment for diagnosing and treating the patient, not for filing the paperwork.
Public Health News: Supporters Call It a Seismic Shift
Groups that have campaigned for years on behalf of people who say they were injured by vaccines welcomed the policy as a breakthrough. MAHA Action, a nonprofit advocacy group that supports the administration's health agenda, called it part of a broader push to strengthen vaccine injury research, reporting, and patient care. Its president, Tony Lyons, said the policy changes the incentive structure for American physicians for the first time in a generation and described it as a seismic shift in the way the government learns about, responds to, treats, and compensates for vaccine injuries. Brianne Dressen, co-founder of React19, an advocacy group for vaccine-injured people and their families, said her group had met with CMS back in 2025 to ask for exactly this change. Dressen called the policy a pro-science move, arguing that serious vaccine injuries are among the most complicated conditions a doctor can treat, requiring far more time with the patient and with other providers.
Pediatrician Dr. Michelle Perro also welcomed the change, noting that physicians have long been able to bill for treating adverse reactions to medications, but that no billable code has existed for vaccine-related adverse events. A CMS spokesperson said the plan will also contribute to improved vaccine safety monitoring, and that rigorous surveillance and transparency about what the evidence shows are essential to rebuilding public trust.
Health News Today: Critics Warn About Incentives
Not everyone in medicine is convinced. The Infectious Diseases Society of America told CMS that the code was neither clinically necessary nor advisable as a matter of public health policy, arguing that existing billing codes already cover the evaluation of a patient with new symptoms, whatever their cause. The family physicians' group made a similar point in its September letter, saying the new code overlaps with codes doctors already use.
The deeper criticism is about incentives. If Medicare pays doctors specifically for diagnosing and treating suspected vaccine injuries, critics ask, could the payment nudge some clinicians toward attributing symptoms to vaccination when another explanation is more likely? Medical freedom advocates have long argued that doctors are financially rewarded for administering recommended childhood vaccines; now the payment flows the other way. Perro said such incentives deserve scrutiny, and that the payments should support meticulous clinical work without rewarding a predetermined conclusion. Dressen pushed back on the idea that doctors would profit from the code, saying that evaluating suspected vaccine injuries is often a complex and expensive process. Lyons argued that the plan will incentivize physicians to treat patients rather than prescribe potentially unnecessary medications. The disagreement is about what the payment will actually reward: careful investigation, as its defenders insist, or a particular diagnosis, as its critics fear.
What It Means for Patients
The most immediate question for patients is who the code actually covers. The new code will be valid for Medicare patients, most of whom are 65 or older, and it does not automatically require state Medicaid programs or commercial insurers to provide the same reimbursement. Medicaid is run by individual states, which may adopt the code but are not required to. Medicare Advantage plans must generally cover the same medically necessary services as traditional Medicare, but insurers can negotiate different rates. Private commercial plans are not obligated to reimburse every code Medicare recognizes, though a CMS spokesperson said the new code will be available for other payers to use.
The outlet that first reported the final rule contacted 24 major private insurers to ask whether they intend to reimburse providers under G0576 beginning in 2027. A spokesperson for CVS Health responded that the company is reviewing the new code. No insurer contacted had yet committed to paying for it, which means that for now the change is a Medicare change, and its reach beyond Medicare will depend on decisions insurers make in the coming weeks. For older Americans on Medicare, the practical effect is straightforward: a senior who develops new symptoms after a flu shot or a Covid vaccination can now expect the doctor to have a billing route for the extra time that evaluation takes. Whether that translates into more doctors willing to take on these cases will depend on how widely physicians learn about the code and whether the payment, roughly 32 dollars per 15 minutes, is enough to cover the work.
What Happens Next
The code takes effect on January 1, 2027. Doctors and billing staff will need to learn it exists and what documentation it requires, patient groups will watch whether it makes it easier to find a willing doctor, and insurers will decide whether to follow Medicare's lead. The unresolved question about VAERS reporting is likely to be the first test. Although the health department initially highlighted reimbursement for reporting suspected injuries, the final rule does not explicitly authorize or exclude payment for the time spent completing and submitting those reports, and CMS did not answer a follow-up request seeking clarification before the rule was published. One reason for the ambiguity may be that doctors are already legally obligated to file such reports in certain situations under the National Childhood Vaccine Injury Act of 1986.
In practice, vaccine injuries have traditionally been underreported: a 2011 Harvard Pilgrim study found that fewer than one percent of vaccine-related adverse events are reported to VAERS, the early-warning system that is supposed to catch safety signals. The broader context is a federal compensation system that advocates say has been slow to navigate: as of September 1, 2026, 14,206 Covid-19 injury claims had been filed with the federal compensation program and 63 had been compensated. Whether the new approach works will be judged in the months after January 1, when the first billing data shows how often the code is used. Supporters are calling the change historic. Critics are calling it unnecessary, and possibly counterproductive. Both sides agree on one thing: the policy puts the question of vaccine injury, long argued about in the abstract, into the routine machinery of American medicine, one 15-minute billing unit at a time.
Source: The Guardian